MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients

European Radiology

Volumn 15, Issue 5, 2005, Pages 1060-1068

  Hájek, Milan ^a,b   Adamovičová, Miriam ^c   Herynek, Vít ^a,b   Škoch, Antonín ^a   Jírů, Filip ^a   Křepelová, Anna ^d   Dezortová, Monika ^a,b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

1H MR spectroscopy; Brain iron; Hallervorden Spatz syndrome; Pantothenate kinase associated neurodegeneration; Relaxometry

Indexed keywords

4 AMINOBUTYRIC ACID; BOTULINUM TOXIN; CLONAZEPAM; FERRITIN; GLUTAMIC ACID; GLUTAMINE; IRON; LEVODOPA; PANTOTHENATE KINASE;

ADOLESCENT; ARTICLE; BASAL GANGLION; CASE REPORT; CONCENTRATION RESPONSE; DISEASE COURSE; DISEASE EXACERBATION; DYSKINESIA; DYSTONIA; FEMALE; GENE MUTATION; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HUMAN; HYPERACTIVITY; MALE; METABOLITE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOBULBAR PALSY; SPEECH DISORDER; SYMPTOMATOLOGY; GENETICS; METABOLISM; MUTATION; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADOLESCENT; FEMALE; HALLERVORDEN-SPATZ SYNDROME; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUTATION; STATISTICS, NONPARAMETRIC;

EID: 22844447872     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2553-4     Document Type: Article

References (33)

1. Hayflick SJ (2003) Pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). J Neurol Sci 207:106-107 10.1016/ S0022-510X(02)00433-1
2. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J., Hayflick S.J. 2001 A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28 4 345-349 10.1038/ng572
3. Vogl T, Bauer M, Seiderer M, Rath M (1984) Nuclear magnetic resonance in the Hallervorden-Spatz syndrome. Digitale Bilddiagn 4(2):66-68 1:STN:280:BiuB1czotF0%3D
4. Littrup PJ, Gebarski SS (1985) MR imaging of Hallervorden-Spatz disease. J Comput Assist Tomogr 9(3):491-493 1:STN:280:BiqC1czjtVE%3D
5. Pedespan J.M., Fontan D., Castell J.F., Langlade P., Guillard J.M. 1993 Contribution of nuclear magnetic imaging in the diagnosis of Hallervorden-Spatz syndrome. Arch Fr Pediatr 50 1 35-37 1:STN:280:ByyB1c3nsFE%3D
6. Hayflick S.J., Westaway S.K., Levinson B., Zhou B., Johnson M.A., Ching K.H., Gitschier J. 2003 Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348 1 33-40 10.1056/ NEJMoa020817
7. Perry T.L., Norman M.G., Yong V.W., Whiting S., Crichton J.U., Hansen S., Kish S.J. 1985 Hallervorden-Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 18 482-489 1:STN:280:BimD2srotFw%3D
8. Rouault TA (2001) Iron on the brain. Nat Genet 28(4):299-300 10.1038/ 91036
9. Vymazal J., Brooks R.A., Patronas N., Hajek M., Bulte J.W.M., Di Chiro G. 1995 Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci 134 Suppl 19-26 10.1016/0022-510X(95)00204-F
10. Roy CN, Andrews NC (2001) Recent advances in disorders of iron metabolism: Mutation, mechanism and modifiers. Hum Mol Genet 10:2181-2186 10.1093/hmg/10.20.2181
11. Vymazal J., Brooks R.A., Zak O., McRill C., Shen C., Di Chiro G. 1992 T1 and T2 of ferritin at different field strengths: Effect on MRI. Magn Reson Med 27 2 368-374 1:CAS:528:DyaK3sXhvVGqsw%3D%3D
12. Bulte J.W.M., Vymazal J., Brooks R.A., Pierpaoli C., Frank J.A. 1992 Frequency dependence of MR relaxation times. II. Iron oxides. J Magn Reson Imaging 3 641-648
13. Brooks R.A., Vymazal J., Bulte J.W.M., Baumgarner C.D., Tran V. 1995 Comparison of T2 relaxation in blood, brain and ferritin. J Magn Reson Imaging 5 4 446-450 1:STN:280:BymD2c%2Fmt1Q%3D
14. Allkemper T, Schwindt W, Maintz D, Heindel W, Tombach B (2004) Sensitivity of T2-weighted FSE sequences towards physiological iron depositions in normal brains at 1.5 and 3.0T. Eur Radiol 14:1000-1004 10.1007/s00330-004-2241-4
15. Schenker C, Meier D, Wichmann W, Boesiger P, Valavanis A (1993) Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 35(2):119-124 1:STN:280:ByyC28rhsFM%3D
16. Dezortová M, Hájek M, Tintěra J, Hejcmanová L, Syková E (2001) MR in phenylketonuria-related brain lesions. Acta Radiol 42 5 459-466 10.1034/j.1600-0455.2001.420505.x
17. Herynek V, Babis M, Trunecka P, Filip K, Vymazal J, Dezortova M, Hajek M (2001) Chronic liver disease: Relaxometry in the brain after liver transplantation. MAGMA 12(1):10-15 1:STN:280:DC%2BD3MzjvFGrtw%3D%3D
18. Starcuk Z, Starcukova J (2003) Determination of conficence region of model parameters in mono- and biexponential fitting of relaxation curves. Proc Int Soc Mag Reson Med 11:1102
19. Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41-51 1:CAS:528:DyaG1MXlslCluw%3D%3D
20. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
21. Hájek M, Burian M, Dezortová M 2000 Application of LCModel for quality control and quantitative in vivo 1H MR spectroscopy by short echo time STEAM sequence. MAGMA 10 6-17 10697221
22. Jírů F, Dezortová M, Burian M, Hájek M 2003 The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques. MAGMA 16 135-143 14564645
23. Sener RN (2003) Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings. Am J Neuroradiol 24:1690-1693 13679293
24. Dooling E.C., Schoene W.C., Richardson Jr. E.P. 1974 Hallervorden-Spatz syndrome. Arch Neurol 30 70-83 1:STN:280:CSuD2cvjvFI%3D
25. Vakili S, Drew AL, Von Schuching S, Becker D, Zeman W (1977) Hallervorden-Spatz syndrome. Arch Neurol 34:729-738 1:STN:280:CSeD2Mbntl0%3D
26. Voelkl A, Ule G (1972) Spurenelementen im menschlichen Gehirn:Altersabhaengigkeit der Eisenkoncentration in 13 verschiedenen Hirnregionen. J Neurol 202:331-338 10.1007/BF00316180
27. Vymazal J, Hajek M, Patronas N, Giedd J.N., Bulte J.W.M., Baumgarner B.S., Tran V., Brooks R.A. 1995 The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 5 554-560 1:STN:280:BymC3cjmsVc%3D
28. Dobson J (2001) Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 496:1-5 10.1016/S0014-5793(01)02386-9
29. Koga H, Kondo A, Kimura T, Takamatsu J (1998) Familial multiple system degeneration associated with iron deposition: Determination of subcellular localization of elementary iron by energy-dispersive X-ray analysis. Clin Neuropathol 17:35-40 1:STN:280:DyaK1c7lslKhsQ%3D%3D
30. 1) of various metal chelates (web compilation-latest revision May 28, 2001) CRC Boca Raton
31. Vymazal J, Bulte JW, Frank JA, Di Chiro G, Brooks RA (1993) Frequency dependence of MR relaxation times. I. Paramagnetic ions. J Magn Reson Imaging 3:637-640 1:STN:280:ByyA2M%2Fjs1w%3D
32. Atamna H, Walter PB, Ames BN (2002) The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 397:345-353 10.1006/abbi.2001.2671
33. Kress G.J., Dineley K.E., Reynolds I.J. 2002 The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes. J Neurosci 22:5848-5855 1:CAS:528:DC%2BD38XlsFOjs7c%3D